MAJOR CUSTOMERS, PARTNERSHIPS AND STRATEGIC ALLIANCES - Genentech, Inc. (Details) $ in Thousands	1 Months Ended	3 Months Ended		9 Months Ended
	Aug. 31, 2024 USD ($) performance_obligation	Sep. 30, 2024 USD ($)	Sep. 30, 2023 USD ($)	Sep. 30, 2024 USD ($)	Sep. 30, 2023 USD ($)	Oct. 31, 2024 USD ($)	Dec. 31, 2023 USD ($)
Research and Development Arrangement, Contract to Perform for Others [Line Items]
Deferred revenues		$ 774		$ 774			$ 0
Revenues		49,412	$ 9,398	50,249	$ 174,190
Genentech, Inc.
Research and Development Arrangement, Contract to Perform for Others [Line Items]
Royalty obligation, term	10 years
Revenues		49,226	0	49,226	0
License | Genentech, Inc.
Research and Development Arrangement, Contract to Perform for Others [Line Items]
Contract with customer liability	$ 40,000
Variable consideration amount	1,900,000
Remaining performance obligation amount	$ 50,000
Number of performance obligations | performance_obligation	2
Receivables		10,000		10,000
Deferred revenues		800		800
Revenues		$ 48,679	$ 0	$ 48,679	$ 0
License | Genentech, Inc. | Subsequent Event
Research and Development Arrangement, Contract to Perform for Others [Line Items]
Contract with customer liability						$ 10,000
License, Technology Transfer | Genentech, Inc.
Research and Development Arrangement, Contract to Perform for Others [Line Items]
Contract with customer liability	$ 10,000